1.
Anand M, Randhawa GK, Salwan SK. A prospective, randomised, open label study to compare efficacy and safety of hydroxychloroquine and teneligliptin in patients of type 2 diabetes mellitus refractory to concomitant metformin and glimepiride. Int J Basic Clin Pharmacol [Internet]. 2023 Feb. 22 [cited 2025 Oct. 23];12(2):192-8. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5211